# Molina Healthcare, Inc.: Form 10-K for the period ended Dec 31, 2021

- Company: [Molina Healthcare, Inc.](/companies/moh.md) (CIK 1179929)
- Form: 10-K
- Filed: 2022-02-14
- Accepted by EDGAR: Feb 14, 2022, 17:12 ET
- Period: 2021-12-31
- Accession: 0001179929-22-000025
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1179929/000117992922000025/moh-20211231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1179929/000117992922000025/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2021-01-01 to 2021-12-31 | $27.77bn | us-gaap:Revenues |
| Cost of revenue | 12 months, 2021-01-01 to 2021-12-31 | $23.70bn | us-gaap:CostOfGoodsAndServicesSold |
| Operating income | 12 months, 2021-01-01 to 2021-12-31 | $1.02bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2021-01-01 to 2021-12-31 | $120.0m | us-gaap:InterestExpense |
| Income tax | 12 months, 2021-01-01 to 2021-12-31 | $216.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2021-01-01 to 2021-12-31 | $659.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2021-01-01 to 2021-12-31 | $11.25 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2021-01-01 to 2021-12-31 | $11.40 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2021-01-01 to 2021-12-31 | 58,600,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2021-01-01 to 2021-12-31 | $2.12bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2021-01-01 to 2021-12-31 | $77.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months, 2021-01-01 to 2021-12-31 | $128.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2021-12-31 | $4.44bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-12-31 | $10.06bn | us-gaap:AssetsCurrent |
| Total assets | at 2021-12-31 | $12.21bn | us-gaap:Assets |
| Current liabilities | at 2021-12-31 | $7.05bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2021-12-31 | $9.58bn | us-gaap:Liabilities |
| Long-term debt | at 2021-12-31 | $2.17bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2021-12-31 | $2.63bn | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1179929/000117992922000025/moh-20211231.htm

Filed Feb 14, 2022.
Source: SEC EDGAR, the filing index for accession 0001179929-22-000025. Last ingested by Listed: Nov 15, 2026, 00:39 ET. No prices; not investment advice.
